4.5 Article

Synthesis of [11C]GSK1482160 as a new PET agent for targeting P2X7 receptor

Journal

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 25, Issue 9, Pages 1965-1970

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2015.03.021

Keywords

[C-11]GSK1482160; Radiosynthesis; Positron emission tomography (PET); P2X(7) receptor; Neuroinflammation

Funding

  1. Indiana University Department of Radiology and Imaging Sciences
  2. Indiana State Department of Health (ISDH) Indiana Spinal Cord & Brain Injury Fund in the United States [ISDH EDS-A70-2-079612]
  3. United States National Science Foundation (NSF) Major Research Instrumentation Program (MRI) grant [CHE-0619254]

Ask authors/readers for more resources

The authentic standards GSK1482160 and its isomer, as well as the radiolabeling precursors desmethyl-GSK1482160 and Boc-protected desmethyl-GSK1482160 were synthesized from L-pyroglutamic acid, methyl L-pyroglutamate and 2-chloro-3-(trifluoromethyl) benzylamine with overall chemical yield 27-28% in 3 steps, 58% in 4 steps, 76% in 1 step and 33% in 2 steps, respectively. [C-11]GSK1482160 was prepared from either desmethyl-GSK1482160 or Boc-protected desmethyl-GSK1482160 with [C-11]CH3OTf through N-[C-11] methylation and isolated by HPLC combined with SPE in 40-50% and 30-40% radiochemical yield, respectively, based on [C-11]CO2 and decay corrected to end of bombardment (EOB). The radiochemical purity was >99%, and the specific activity at EOB was 370-1110 GBq/mu mol with a total synthesis time of similar to 40-min from EOB. (C) 2015 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available